Metabolic syndrome
Subtitle: underlying mechanisms and drug therapies
By: edited by Minghan Wang
Publisher: John Wiley & Sons
Published: 2011
Place of publication: Hoboken, N.J
Language: eng
Number of pages: 494
ISBN-13: 9780470343425
Subjects: Pathophysiology; Drug therapy; Physiopathology; Chemotherapy; Metabolic Syndrome X; Metabolic syndrome
Notes: Includes bibliographical references and index.
Table of contents: title: Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism / Minghan Wang; title: Central glucose sensing and control of food intake and energy homeostasis / Lourdes Mounien and Bernard Thorens; title: Abnormalities in insulin secretion in type 2 diabetes mellitus / Taly Meas and Pierre-Jean Guillausseau; title: Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae / Vanessa DeClercq ... [et al.]; title: Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis / Ruojing Yang; title: Energy metabolism in skeletal muscle and its link to insulin resistance / Minghan Wang; title: Mechanisms and complications of metabolic syndrome / Minghan Wang; title: Emerging therapeutic approaches for dyslipidemias associated with high LDL and low HDL / Margrit Schwarz and Jae B. Kim; title: Mechanism of action of niacin : implications for atherosclerosis and drug discovery / Devan Marar ... [et al.]; title: Current antidiabetic therapies and mechanisms / Minghan Wang; title: GLP-1 biology, signaling mechanisms, physiology, and clinical studies / Remy Burcelin ... [et al.]; title: Dipeptidyl peptidase IV inhibitors for treatment of diabetes / McIntosh, C.H.S. ... [et al.]; title: Sodium glucose co-transporter 2 inhibitors / Margaret Ryan and Serge A. Jabbour; title: Fibroblast growth factor 21 as a novel metabolic regulator / Radmila Micanovic, James D. Dunbar, and Alexei Kharitonenkov; title: Sirtuins as potential drug targets for metabolic diseases / Qiang Tong; title: 11-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes / Clarence Hale and David J. St. Jean, Jr; title: Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade / Hai Yan, Wei Gu, and Murielle Veniant-Ellison; title: Drug development for metabolic diseases: past, present and future / Minghan Wang.